Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Malignant mesenchymal tumor × pegfilgrastim × Clear all

Sponsor

Conditions

Breast Neoplasms 24 Lymphoma 14 Neutropenia 9 Lymphoma, Large B-Cell, Diffuse 7 Leukemia 7 Neoplasms 6 Lymphoma, Follicular 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Triple Negative Breast Neoplasms 4 Hodgkin Disease 4 Chemotherapy-induced Neutropenia 4 Carcinoma, Non-Small-Cell Lung 4 Urinary Bladder Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Ovarian Neoplasms 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Mantle-Cell 3 Lymphoma, B-Cell, Marginal Zone 3 Colorectal Neoplasms 3 Breast Neoplasms, Male 3 Waldenstrom Macroglobulinemia 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Lymphoma, T-Cell, Peripheral 2 Lung Neoplasms 2

Interventions

Radiotherapy, Conformal 2 Ifosfamide 2 Doxorubicin 2 romidepsin 1 indolepropanol phosphate 1 etoposide phosphate 1 Watchful Waiting 1 Vincristine 1 Sunitinib 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Polymerase Chain Reaction 1 Observation 1 Neoadjuvant Therapy 1 Irinotecan 1 HhAntag691 1 Granulocyte Colony-Stimulating Factor 1 Gene Expression Profiling 1 Filgrastim 1 Etoposide 1 Dactinomycin 1 Cyclophosphamide 1 Blotting, Western 1 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡